113 related articles for article (PubMed ID: 3156755)
1. Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
Affolter H; Burkard WP; Pletscher A
Eur J Pharmacol; 1985 Jan; 108(2):157-62. PubMed ID: 3156755
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.
Adachi H; Shoji T
Jpn J Pharmacol; 1986 Aug; 41(4):431-5. PubMed ID: 3773338
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600.
Taylor JE; Defeudis FV
Eur J Pharmacol; 1984 Oct; 106(1):215-6. PubMed ID: 6529970
[No Abstract] [Full Text] [Related]
4. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
5. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
De Clerck F; Xhonneux B; Leysen J; Janssen PA
Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
[TBL] [Abstract][Full Text] [Related]
6. The 5-hydroxytryptamine receptor of blood platelets.
Pletscher A; Affolter H
J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
[TBL] [Abstract][Full Text] [Related]
7. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
8. Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.
Pietraszek MH; Buczko W
Eur J Pharmacol; 1987 Jun; 137(2-3):273-5. PubMed ID: 3609146
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.
Dehpour AR; Samadian T; Akhavan MM; Meysamee F; Delfan A
Gen Pharmacol; 1995 Oct; 26(6):1295-9. PubMed ID: 7590122
[TBL] [Abstract][Full Text] [Related]
10. Characterization of serotonin binding sites on human platelets.
McBride PA; Mann JJ; McEwen B; Biegon A
Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.
Affolter H; Erne P; Bürgisser E; Pletscher A
Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):337-42. PubMed ID: 6427633
[TBL] [Abstract][Full Text] [Related]
12. Absence of (-) [3H]desmethoxyverapamil binding sites on human platelets and lack of evidence for voltage-dependent calcium channels.
Pannocchia A; Praloran N; Arduino C; Della Dora N; Bazzan M; Schinco P; Buraglio M; Pileri A; Tamponi G
Eur J Pharmacol; 1987 Oct; 142(1):83-91. PubMed ID: 2446886
[TBL] [Abstract][Full Text] [Related]
13. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
15. Effects of verapamil on the release of different neurotransmitters.
Sitges M; Reyes A
J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
[TBL] [Abstract][Full Text] [Related]
16. Participation of intracellular sites in the action of Ca2+ channel blockers.
White EJ; Bradford HF
Eur J Pharmacol; 1986 Nov; 130(3):243-8. PubMed ID: 3792448
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
Rehavi M; Carmi R; Weizman A
Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
[TBL] [Abstract][Full Text] [Related]
18. Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.
Erne P; Pletscher A
Br J Pharmacol; 1985 Feb; 84(2):545-9. PubMed ID: 3156650
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
Lampugnani MG; de Gaetano G
Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
[No Abstract] [Full Text] [Related]
20. [Mechanism of action of various psychotropic agents on serotonin receptors and the transmembrane signal control].
Mikuni M
Hokkaido Igaku Zasshi; 1987 May; 62(3):417-29. PubMed ID: 3610034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
